JW (Cayman) Therapeutics Co. Ltd
Status: Publicly traded
Direct answer
JW (Cayman) Therapeutics Co. Ltd is publicly traded on HKSE under the ticker 2126.HK.
JW (Cayman) Therapeutics Co. Ltd is a clinical-stage biotechnology company dedicated to the development, manufacture, and commercialization of cell-based immunotherapies. The company primarily targets hematological cancers and solid tumors through treatments that harness the body's own immune cells to combat disease, notably including CAR-T therapies. Its leading therapeutic candidate is Carteyva (relmacabtagene...
Can you invest in JW (Cayman) Therapeutics Co. Ltd?
Yes. JW (Cayman) Therapeutics Co. Ltd trades publicly on HKSE as 2126.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for JW (Cayman) Therapeutics Co. Ltd
Detailed equity research is provided by MarketSnap.